---
schema_version: "secwatch.filing_event.v1"
accession: "0001193805-26-000916"
form_type: "8-K"
ticker: "IMUX"
cik: "0001280776"
company_name: "IMMUNIC, INC."
filed_at: "2026-07-06T20:22:14+00:00"
generated_at: "2026-07-06T20:23:13.470406+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Director Tamar Howson resigns; CEO Erik Lundgren appointed to board

## Summary
- Tamar Howson resigned from Board and Compensation Committee effective June 29, 2026, due to retirement; no disagreement.
- On July 5, 2026, Board appointed CEO Erik Lundgren as Class II director until 2028 annual meeting.
- Lundgren will not serve on any board committee and receives no additional compensation for director role.
- Lundgren's existing employment agreement with Immunic was previously disclosed (May 27, 2026 8-K).

## SEC filing metadata
- accession: 0001193805-26-000916
- form_type: 8-K
- ticker: IMUX
- cik: 0001280776
- company_name: IMMUNIC, INC.
- filed_at: 2026-07-06T20:22:14+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1280776/000119380526000916/0001193805-26-000916-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1280776/000119380526000916/e665619_8k-immunic.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193805-26-000916
- JSON: https://secwatch.observer/filing/0001193805-26-000916.json
- Plain text: https://secwatch.observer/filing/0001193805-26-000916.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.